Vineet Kumar Maurya

Vineet Kumar Maurya

Auto-generated profile, based on publicly available information

Vineet Kumar Maurya

Department of Molecular and Cellular Biology, Baylor College of Medicine , Houston, TX

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2015 in Biology of Reproduction
Verified
Journal Article
Open access
VKVijay Kumar
Vijay Kumar
VMVineet Kumar Maurya
Vineet Kumar Maurya
AJAnubha Joshi
Anubha Joshi
SMSyed Musthapa Meeran
Syed Musthapa Meeran
RJRajesh Kumar Jha
Rajesh Kumar Jha
Integrins (ITGs) are mediators of cell-cell and cell-matrix interactions, which are also associated with embryo implantation processes by controlling

27 June 2022 in Reproduction
Verified
Journal Article
Closed access
PDF file
VMVineet K Maurya
Vineet K Maurya
MSMaria M Szwarc
Maria M Szwarc
RFRodrigo Fernandez-Valdivia
Rodrigo Fernandez-Valdivia
DLDavid M Lonard
David M Lonard
SYSong Yong
Song Yong
JLJohn Peter Lydon
John Peter Lydon
Although a non-malignant gynecological disorder, endometriosis displays some pathogenic features of malignancy, such as cell proliferation, migration, invasion and adaptation to hypoxia. Current treatments of endometriosis include pharmacotherapy and/or surgery, which are of limited efficacy and often associated with adverse side effects. Therefore, to develop more effective therapies to treat this disease, a broader understanding of the underlying molecular mechanisms that underpin endometriosis needs to be attained. Using immortalized human endometriotic epithelial and stromal cell lines, we demonstrate that the early growth response 1 (EGR1) transcription factor is essential for cell proliferation, migration and invasion, which represent some of the pathogenic properties of endometriotic cells. Genome-wide transcriptomics identified an EGR1-dependent transcriptome in human endometriotic epithelial cells that potentially encodes a diverse spectrum of proteins that are known to be involved in tissue pathologies. To underscore the utility of this transcriptomic data set, we demonstrate that carbonic anhydrase 9 (CA9), a homeostatic regulator of intracellular pH, is not only a molecular target of EGR1 but is also important for maintaining many of the cellular properties of human endometriotic epithelial cells that are also ascribed to EGR1. Considering therapeutic intervention strategies are actively being developed for EGR1 and CAIX in the treatment of other pathologies, we believe EGR1 and its transcriptome (which includes CA9) will offer not only a new conceptual framework to advance our understanding of endometriosis but will also furnish new molecular vulnerabilities to be leveraged as potential therapeutic options in the future treatment of endometriosis.

14 November 2023 in The FASEB Journal
Verified
Journal Article
Open access
VMVineet K. Maurya
Vineet K. Maurya
MSMaria M. Szwarc
Maria M. Szwarc
DLDavid M. Lonard
David M. Lonard
RKRamakrishna Kommagani
Ramakrishna Kommagani
SWSan Pin Wu
San Pin Wu
JLJohn Peter Lydon
John Peter Lydon
Although we have shown that steroid receptor coactivator‐2 (SRC‐2), a member of the p160/SRC family of transcriptional coregulators, is essential for decidualization of both human and murine endometrial stromal cells, SRC‐2's role in the earlier stages of the implantation process have not been adequately addressed. Using a conditional SRC‐2 knockout mouse ( SRC‐2 d/d ) in timed natural pregnancy studies, we show that endometrial SRC‐2 is required for embryo attachment and adherence to the luminal epithelium. Implantation failure is associated with the persistent expression of Mucin 1 and E‐cadherin on the apical surface and basolateral adherens junctions of the SRC‐2 d/d luminal epithelium, respectively. These findings indicate that the SRC‐2 d/d luminal epithelium fails to exhibit a plasma membrane transformation (PMT) state known to be required for the development of uterine receptivity. Transcriptomics demonstrated that the expression of genes involved in steroid hormone control of uterine receptivity were significantly disrupted in the SRC‐2 d/d endometrium as well as genes that control epithelial tight junctional biology and the emergence of the epithelial mesenchymal transition state, with the latter sharing similar biological properties with PMT. Collectively, these findings uncover a new role for endometrial SRC‐2 in the induction of the luminal epithelial PMT state, which is a prerequisite for the development of uterine receptivity and early pregnancy establishment.


22 July 2023 in Genesis
Verified
Journal Article
Closed access
VMVineet K. Maurya
Vineet K. Maurya
YYYan Ying
Yan Ying
DLDenise G. Lanza
Denise G. Lanza
JHJason D. Heaney
Jason D. Heaney
JLJohn Peter Lydon
John Peter Lydon

5 October 2026 in Reproduction
Verified
Journal Article
Open access
VMVineet K Maurya
Vineet K Maurya
SGSivagami Gunasekaran
Sivagami Gunasekaran
NMNisha Misra
Nisha Misra
DLDavid M Lonard
David M Lonard
PPPooja Popli
Pooja Popli
JLJohn P Lydon
John P Lydon
In brief: Although endometriosis is known to be a debilitating gynecological disease associated with chronic pelvic pain and infertility, our understanding of its molecular underpinnings is incomplete. Using experimentally induced nonhuman primate and murine endometriosis tissue along with a human ectopic endometriosis epithelial cell line, we reveal that steroid receptor coactivator-2 (and its downstream target S100A10) are important for the pathogenic properties of ectopic endometriotic epithelial cells, potentially providing new molecular vulnerabilities for future therapeutic invention. Commonly diagnosed in reproductive-age women, endometriosis is causally linked to subfertility, infertility, and chronic pelvic pain. Although theories exist on the etiopathogenesis of endometriosis, our understanding of its cellular and molecular underpinnings remain incomplete. We report that steroid receptor coactivator-2 (SRC-2), a member of the p160/SRC family of transcriptional coregulators, is expressed predominantly in epithelial cells of ectopic endometriotic lesions in the primate and mouse. Using an immortalized human endometriosis epithelial cell (iHEEC) line in conjunction with small interfering RNA–mediated silencing, we demonstrate that SRC-2 is essential for many of the pathogenic features ascribed to endometriotic lesion expansion, including sustained viability along with clonogenic, migratory, and invasive properties. Genome-scale iHEEC RNA-sequencing analysis implicates SRC-2 in a number of pathobiologies associated with the cellular phenotype of the ectopic endometriotic epithelial cell, including actin cytoskeleton reorganization. To underscore the utility of this RNA-sequencing dataset, we show that S100A10, a cytoarchitectural scaffolding protein, is responsive to SRC-2 and essential for many of the above cellular properties of the iHEEC that are ascribed to SRC-2. Because S100A10 dysregulation is strongly linked to the etiopathogenesis of a wide spectrum of malignancies, many of the molecular mechanisms that underlie S100A10’s role in cancer progression are predicted to be coopted in endometriosis. Therefore, these investigations highlight an unsuspected role for SRC-2 (and its transcriptome) in maintaining the pathogenetic phenotype of the ectopic endometriotic epithelial cell. Such findings support continued investigations of this coactivator and its downstream gene expression programs as potential targets for the prognosis, diagnosis, and/or treatment of this gynecological disorder in the future.